PharmaShots | Incisive News in 3 Shots

Subscribe Now

Social Anxiety Disorder

VistaGen Therapeutics Reports Positive Results of PH94B in P-III study for Social Anxiety Disorder (SAD)

VistaGen Therapeutics Reports Positive Results of PH94B in P-III study for Social Anxiety Disorder (SAD)

April 2, 2019

VistaGen Therapeutics Acquires WW Rights for Pherin's PH94B nasal spray for the Treatment of Social Anxiety Disorder

VistaGen Therapeutics Acquires WW Rights for Pherin's PH94B nasal spray for the Treatment of Social Anxiety Disorder

September 14, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us